Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases

Details for Australian Patent Application No. 2005260031 (hide)

Owner Amgen Inc.

Inventors Liu, Longin; Hong, Fang-Tsao; Anderson, Denise Lyn; Lopez, Patricia; Frohn, Michael J.

Agent Shelston IP

Pub. Number AU-B-2005260031

PCT Pub. Number WO2006/004702

Priority 60/583,150 25.06.04 US

Filing date 24 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 9 October 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/004702 Priority application(s): WO2006/004702

9 October 2008 Application Accepted

  Published as AU-B-2005260031

5 February 2009 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260032-Pyrrolo[2,3-d]pyrimidines that modulate ACK1 and LCK activity

2005260026-Computerized system for automated completion of forms